Literature DB >> 29550536

Salivary alpha-amylase and cortisol responsiveness to stress in first episode, drug-naïve patients with panic disorder.

Mario Altamura1, Salvatore Iuso2, Angela Balzotti2, Girolamo Francavilla2, Andrea Dimitri2, Giuseppe Cibelli3, Antonello Bellomo2, Annamaria Petito2.   

Abstract

Reported findings on reactivity to stress of the sympathetic-adreno-medullar (SAM) and hypothalamic-pituitary-adrenal (HPA) systems in panic disorder (PD) are very variable. This inconsistency may be explained by differences in treatment exposure, illness duration and emotion regulation strategies. The present study examined the reactivity to mental stress of the SAM and HPA axes in a sample of first episode, drug naïve patients with PD which avoids confounds of medications exposure and illness chronicity. Activation of the SAM axis was evaluated by dosage of salivary alpha-amylase (sAA) and heart rate. Activation of the HPA axis was tested by dosage of salivary cortisol. Psychological assessments were done by the Self-Rating Depression Scale, the Self-Rating Anxiety Scale, the State-Trait Anxiety Inventory, the Cope Orientation to Problems Experienced (COPE) Inventory and the 16 Personality Factor Questionnaire (16PF). Patients showed reduced sAA stress reactivity, higher baseline cortisol levels and a more rapid decrease in stress cortisol levels as compared with controls. A significant correlation was found between active coping strategies and cortisol levels (response to stress). The findings suggest that blunted SAM stress reactivity and a rapid decrease in stress cortisol levels reflect traits that may enhance vulnerability to psychopathology in patients with PD.
Copyright © 2018 Elsevier B.V. and Japan Neuroscience Society. All rights reserved.

Entities:  

Keywords:  HPA axis; Panic disorder; SAM system; Salivary alpha-amylase; Salivary cortisol; Stress reactivity

Mesh:

Substances:

Year:  2018        PMID: 29550536     DOI: 10.1016/j.neures.2018.03.003

Source DB:  PubMed          Journal:  Neurosci Res        ISSN: 0168-0102            Impact factor:   3.304


  6 in total

1.  Physiological and psychological stress in pregnant women with quiescent inflammatory bowel disease: A pilot study using salivary biomarkers.

Authors:  Jennifer Khil; Sherman Picardo; Cynthia H Seow; Yvette Leung; Amy Metcalfe; Elnaz E Afshar; Nastaran Sharifi; Tavis Campbell; Nicole Letourneau; Deborah Dewey; Gerald F Giesbrecht
Journal:  JGH Open       Date:  2020-03-04

2.  Stressful Life Memories Relate to Ruminative Thoughts in Women With Sexual Violence History, Irrespective of PTSD.

Authors:  Emma M Millon; Han Yan M Chang; Tracey J Shors
Journal:  Front Psychiatry       Date:  2018-09-05       Impact factor: 4.157

3.  The role of acid-sensitive ion channels in panic disorder: a systematic review of animal studies and meta-analysis of human studies.

Authors:  Laiana A Quagliato; Rafael C Freire; Antonio E Nardi
Journal:  Transl Psychiatry       Date:  2018-09-07       Impact factor: 6.222

4.  T2DM patients with depression have higher levels of hyperglycemia and cognitive decline than T2DM patients.

Authors:  Savitree Thummasorn; Sopida Apichai; Supat Chupradit; Pornpen Sirisattayawong; Pachpilai Chaiwong; Sirawit Sriwichaiin; Wasana Pratchayasakul; Nipon Chattipakorn; Siriporn C Chattipakorn
Journal:  PLoS One       Date:  2022-08-19       Impact factor: 3.752

5.  Coordination of autonomic and endocrine stress responses to the Trier Social Stress Test in adolescence.

Authors:  Sarah Glier; Alana Campbell; Rachel Corr; Andrea Pelletier-Baldelli; Mae Yefimov; Carina Guerra; Kathryn Scott; Louis Murphy; Joshua Bizzell; Aysenil Belger
Journal:  Psychophysiology       Date:  2022-03-30       Impact factor: 4.348

6.  Cortisol response under low intensity exercise during cognitive-behavioral therapy is associated with therapeutic outcome in panic disorder-an exploratory study.

Authors:  Gloria-Beatrice Wintermann; René Noack; Susann Steudte-Schmiedgen; Kerstin Weidner
Journal:  PLoS One       Date:  2022-09-01       Impact factor: 3.752

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.